Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
alessandro.sciarra@uniroma1.it
Alessandro Sciarra
Professore Ordinario
Struttura:
DIPARTIMENTO MATERNO INFANTILE E SCIENZE UROLOGICHE
E-mail:
alessandro.sciarra@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Which factors can influence post-operative renal function preservation after nephron-sparing surgery for kidney cancer: a critical review
CENTRAL EUROPEAN JOURNAL OF UROLOGY
2022
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide
MINERVA UROLOGY AND NEPHROLOGY
2022
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study
MINERVA UROLOGY AND NEPHROLOGY
2022
The accuracy of vesical imaging-reporting and data system (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations
WORLD JOURNAL OF UROLOGY
2022
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study
ESMO OPEN
2022
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy
DIAGNOSTICS
2022
Influence of COVID-19 pandemic on timing and outcomes of treatment for acute testicular torsion in adults: a single institution experience
THE CANADIAN JOURNAL OF UROLOGY
2022
Quantitative analysis of urinary incontinence after prostatectomy: lack of standardization in trials
MINERVA UROLOGY AND NEPHROLOGY
2022
Comment on: Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis
MINERVA UROLOGY AND NEPHROLOGY
2022
Regenerative medicine-based treatment of stress urinary incontinence with stem cells: a systematic review and meta-analysis
CURRENT STEM CELL RESEARCH & THERAPY
2022
Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms
PROSTATE CANCER AND PROSTATIC DISEASES
2022
Comparison of Different Invasive Devices for the Treatment of Urinary Incontinence after Radical Prostatectomy
ADVANCES IN UROLOGY
2022
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry
FRONTIERS IN ONCOLOGY
2022
Radiomics in prostate cancer: an up-to-date review
THERAPEUTIC ADVANCES IN UROLOGY
2022
Features of patients referring to the outpatient office due to benign prostatic hyperplasia: analysis of a national prospective cohort of 5815 cases
PROSTATE CANCER AND PROSTATIC DISEASES
2022
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Impact of early self-clean intermittent catheterization in orthotopic ileal neobladder: prospective randomized study to evaluate functional outcomes, continence status and urinary tract infections
MINERVA UROLOGY AND NEPHROLOGY
2022
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)
WORLD JOURNAL OF UROLOGY
2022
Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and peri-operative outcomes
MINERVA UROLOGY AND NEPHROLOGY
2022
Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic Prostate Cancer
CURRENT ONCOLOGY
2022
« prima
< precedente
1
2
3
4
5
6
7
8
9
seguente ›
ultima »
Progetti di Ricerca
Evaluation of serum thymidine kinase 1 (TK1) as a biomarker for follow-up and prediction of progression in early-stage and advanced prostate cancer patients.
Valutazione dei tratti premorbosi temperamentali e degli stili di coping nello sviluppo di Disturbi Depressivi in pazienti affetti da neoplasia prostatica: influenza delle diverse terapie oncologiche e degli aspetti funzionali.
Implementation of SelectMDx non-invasive urinary biomarker-based risk score in the pre-biopsy setting for prostate cancer detection: a prospective study.
Gruppi di ricerca
Integrated Diagnostics in Prostate Cancer supported by Computational Algorithms (AI and network analysis)
Gruppi di ricerca - Responsabile
PROSTATE CANCER SCREENING IN HEALTHY MEN WITH DNA REPAIR GENE MUTATIONS: A GENDER PROSPECTIVE FOR A SUSTAINABLE PERSONALISED MEDICINE
Regenerative medicine-based treatment with injection of autologous muscle-derived or adipose-derived stem cells for the management of stress urinary incontinence : two preclinical models
VALORE PROGNOSTICO DELLE VARIANTI PATOGENETICHE DI GENI DDR (DNA DAMAGE REPAIR) NEI PAZIENTI CON NUOVA DIAGNOSI DI CARCINOMA PROSTATICO O DI NEOPLASIE DELLO STOMACO, PANCREAS E VIE BILIARI: IMPLICAZIONI DELL’ANALISI EREDO-FAMILIARE
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma